SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Aljabery Firas) "

Sökning: WFRF:(Aljabery Firas)

  • Resultat 31-34 av 34
  • Föregående 123[4]
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
31.
  • Malmström, Per Uno, et al. (författare)
  • Incidence, survival and mortality trends of bladder cancer in Sweden 1997–2016
  • 2019
  • Ingår i: Scandinavian Journal of Urology. - Taylor & Francis. - 2168-1805.
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: To evaluate trends in bladder cancer incidence, survival and mortality in Sweden from 1997–2016. Patients and methods: The Swedish National Registry of Urinary Bladder Cancer is a nation-wide quality register that started in 1997. It includes information on initial tumor characteristics and treatment; 41,097 new cases were registered up to 2016. Patients were stratified into four time periods. Deaths were monitored through the national death register. Overall and relative survival in time periods were studied with respect to differences in stage, age and gender. Results: The number of new cases increased by 38% for men and 39% for women from 1997 to 2016. The corresponding age-standardized incidence per 100,000 was less dramatic, with increases of 6% and 21%, respectively, and the increase was most evident in the oldest age group. The survival rate was stable until 2012, but thereafter a significant improvement occurred. The survival trends in stage-groups show that this improvement is found in all categories as well as irrespective of age and gender. The mortality rate during this period was stable for women, but showed a slight decrease for men. The main limitation of this study is the use of administrative data for defining some of the endpoints. Conclusion: The most recent Swedish bladder cancer statistics show an increased incidence, improved survival, but stable mortality.
  •  
32.
  • Ottosson, Kristoffer, et al. (författare)
  • The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access a multicenter evaluation
  • 2019
  • Ingår i: International Urology and Nephrology. - 0301-1623.
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose: To investigate if patients receiving neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) had an increased risk of thromboembolic events (TEE) and to evaluate when these events occur on a timeline starting from 6 months pre-cystectomy, during NAC-administration and 60 months post-cystectomy.Methods: Two hundred and fifty five patients undergoing radical cystectomy during 2009–2014 at three Swedish cystectomy centers (Umeå, Linköping and Sundsvall) were in-detail reviewed retrospectively, using individual medical records. One hundred and twenty nine patients were ineligible for analysis. NAC patients (n = 67) were compared to NAC-naïve NAC-eligible patients (n = 59). The occurrence of TEE was divided into different periods pre-cystectomy and post-cystectomy. Statistical analyses included Chi-squared and logistical regression tests.Results: Significant associations were found between receiving NAC and acquiring a TEE during NAC therapy pre-cystectomy. All but one pre-cystectomy event was venous and all but one of the patients received NAC. 31% (14/45) of TEEs occurred pre-cystectomy. The incidence of TEEs pre-cystectomy in NAC-naive NAC-eligible patients was only 10% (2/20), whereas the incidence of TEEs in NAC patients occurred pre-cystectomy in 48% (12/25) and 11/12 incidents were detected during NAC therapy—this including 7/11 (64%) incidents affecting veins in anatomical conjunction with the placement of central venous access for chemotherapy administration.Conclusions: There is a significantly increased risk for TEE pre-cystectomy during chemotherapy administration in MIBC patients receiving NAC, compared to the risk in NAC-naïve NAC-eligible MIBC patients. In 64% of the pre-RC TEEs in NAC patients, there was a clinical connection to placement of central venous access.
33.
  • Ottosson, Kristoffer, et al. (författare)
  • The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation
  • 2020
  • Ingår i: International Urology and Nephrology. - SPRINGER. - 0301-1623 .- 1573-2584. ; 52, s. 661-669
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose To investigate if patients receiving neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) had an increased risk of thromboembolic events (TEE) and to evaluate when these events occur on a timeline starting from 6 months pre-cystectomy, during NAC-administration and 60 months post-cystectomy. Methods Two hundred and fifty five patients undergoing radical cystectomy during 2009-2014 at three Swedish cystectomy centers (Umea, Linkoping and Sundsvall) were in-detail reviewed retrospectively, using individual medical records. One hundred and twenty nine patients were ineligible for analysis. NAC patients (n = 67) were compared to NAC-naive NAC-eligible patients (n = 59). The occurrence of TEE was divided into different periods pre-cystectomy and post-cystectomy. Statistical analyses included Chi-squared and logistical regression tests. Results Significant associations were found between receiving NAC and acquiring a TEE during NAC therapy pre-cystectomy. All but one pre-cystectomy event was venous and all but one of the patients received NAC. 31% (14/45) of TEEs occurred pre-cystectomy. The incidence of TEEs pre-cystectomy in NAC-naive NAC-eligible patients was only 10% (2/20), whereas the incidence of TEEs in NAC patients occurred pre-cystectomy in 48% (12/25) and 11/12 incidents were detected during NAC therapy-this including 7/11 (64%) incidents affecting veins in anatomical conjunction with the placement of central venous access for chemotherapy administration. Conclusions There is a significantly increased risk for TEE pre-cystectomy during chemotherapy administration in MIBC patients receiving NAC, compared to the risk in NAC-naive NAC-eligible MIBC patients. In 64% of the pre-RC TEEs in NAC patients, there was a clinical connection to placement of central venous access.
  •  
34.
  • Sjöström, Carin, et al. (författare)
  • Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer
  • 2018
  • Ingår i: Scandinavian journal of urology. - TAYLOR & FRANCIS LTD. - 2168-1805. ; 52:3, s. 186-193
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: The aim of this investigation was to study differences between male and female patients with stage T1 urinary bladder cancer (UBC) regarding intravesical instillation therapy, second resection and survival. Materials and methods: This study included all patients with non-metastatic primary T1 UBC reported to the Swedish National Register of Urinary Bladder Cancer (SNRUBC) from 1997 to 2014, excluding those treated with primary cystectomy. Differences between groups were evaluated using chi-squared tests and logistic regression, and survival was investigated using Kaplan-Meier and log-rank tests and Cox proportional hazards analysis. Results: In all, 7681 patients with T1 UBC (77% male, 23% female) were included. Females were older than males at the time of diagnosis (median age at presentation 76 and 74 years, respectively; p amp;lt; .001). A larger proportion of males than females underwent intravesical instillation therapy (39% vs 33%, pamp;lt;.001). Relative survival was lower in women aged amp;gt;= 75 years and women with G3 tumours compared to men. However, women aged amp;gt;= 75 years who had T1G3 tumours and underwent second resection followed by intravesical instillation therapy showed a relative survival equal to that observed in men. Conclusions: This population-based study demonstrates that women of all ages with T1 UBC undergo intravesical instillation therapy less frequently than men, and that relative survival is poorer in women aged amp;gt;= 75 years than in men of the same age when intravesical instillation therapy and second resection are not used. However, these disparities may disappear with treatment according to guidelines.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 31-34 av 34
  • Föregående 123[4]
Åtkomst
fritt online (12)
Typ av publikation
tidskriftsartikel (32)
annan publikation (1)
doktorsavhandling (1)
Typ av innehåll
refereegranskat (28)
övrigt vetenskapligt (6)
Författare/redaktör
Aljabery, Firas, (24)
Sherif, Amir, (23)
Liedberg, Fredrik, (21)
Jahnson, Staffan, (18)
Hosseini, Abolfazl, (16)
Malmström, Per-Uno, (15)
visa fler...
Ströck, Viveka (15)
Gårdmark, Truls (14)
Strock, Viveka, (11)
Holmberg, Lars, (10)
Gardmark, Truls, (9)
Malmstrom, Per-Uno, (9)
Hagberg, Oskar, (7)
Häggström, Christel, (7)
Ullén, Anders (7)
Jerlström, Tomas (6)
Johansson, Markus, (6)
Huge, Ylva (6)
Olsson, Hans, (4)
Riklund, Katrine (4)
Abdul-Sattar Aljaber ... (4)
Haggstrom, Christel, (4)
Jerlstrom, Tomas, (4)
Jerlström, Tomas, 19 ... (4)
Haggstrom, C. (4)
Winqvist, Ola (4)
Alamdari, Farhood (4)
Garmo, Hans (3)
Andrén, Ove (3)
Gardmark, T. (3)
Shabo, Ivan, (3)
Rosell, Johan, (3)
Jakubczyk, Tomasz (3)
Holmström, Benny (3)
Holmstrom, Benny, (3)
Fall, Katja (3)
Gudjonsson, Sigurdur ... (2)
Van Hemelrijck, Miek ... (2)
Gimm, Oliver, (2)
Jerlstrom, T. (2)
Malmstrom, P. U. (2)
Alvaeus, Julia, (2)
Rosenblatt, Robert, (2)
Hemdan, Tammer (2)
Gabrielsson, Susanne (2)
Fall, Katja, 1971-, (2)
De Luna, Xavier, (2)
Hartana, Ciputra Adi ... (2)
Winerdal, Malin E. (2)
Krantz, David (2)
visa färre...
Lärosäte
Linköpings universitet (22)
Umeå universitet (15)
Karolinska Institutet (11)
Lunds universitet (10)
Uppsala universitet (10)
Göteborgs universitet (6)
visa fler...
Örebro universitet (5)
visa färre...
Språk
Engelska (32)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (34)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy